北京
据交易所数据统计，2026年一季报化学制药行业按营业总收入排名，前30家上市公司合计实现营业总收入1000.71亿元，其中12家公司营收同比增长。
营业总收入排名居前的公司包括：华东医药、百济神州、复星医药、恒瑞医药、ST人福。
2026年一季报化学制药行业营业总收入排行（前30家） 排名代码简称营业总收入营收同比归母净利润净利同比1000963华东医药111.83亿元+4.17%10.02亿元+9.56%2688235百济神州105.44亿元+31.02%16.08亿元+1801.3%3600196复星医药100.73亿元+6.93%8.71亿元+13.87%4600276恒瑞医药81.41亿元+12.98%22.82亿元+21.78%5600079ST人福61.01亿元-0.59%5.88亿元+8.85%6002422科伦药业42.59亿元-2.98%4.54亿元-22.34%7600664哈药股份41.75亿元+0.02%1.61亿元-24.33%8600380健康元37.21亿元-8.99%4.15亿元-4.78%9000513丽珠集团28.71亿元-9.73%5.77亿元-9.39%10002004华邦健康28.19亿元-0.08%1.55亿元-16.01%11600062华润双鹤28.07亿元-8.84%4.85亿元-4.3%12000739普洛药业24.47亿元-10.36%2.49亿元+0.19%13000756新华制药24.23亿元-0.28%8390.30万元-25.15%14600267海正药业23.90亿元-9.17%3.56亿元+83.13%15600521华海药业23.35亿元-1.4%4.04亿元+35.9%16600216浙江医药21.91亿元-2.86%2.87亿元-29.84%17600812华北制药21.53亿元-16.36%3547.28万元-38.3%18600420国药现代20.64亿元-20.81%1.38亿元-61.71%19000597东北制药20.06亿元+3.03%2663.11万元-26.68%20600789鲁抗医药16.16亿元-3.42%5325.34万元-32.25%21002262恩华药业16.10亿元+6.58%3.17亿元+5.56%22688578艾力斯15.84亿元+44.19%6.36亿元+54.94%23002653海思科15.64亿元+75.33%5.55亿元+1089.85%24605507国邦医药15.21亿元+5.61%1.61亿元-25.28%25002102ST能特15.21亿元-34.43%2371.05万元-89.42%26002399海普瑞13.31亿元-4.55%1.88亿元+19.79%27002019亿帆医药12.56亿元-5.36%1.07亿元-30.25%28002294信立泰12.28亿元+15.65%2.25亿元+12.45%29301301川宁生物10.94亿元-15.61%1.11亿元-61.58%30300558贝达药业10.40亿元+13.33%2.36亿元+135.71%
本文数据来源于交易所，统计口径为已披露的定期报告，按营业总收入降序排列，仅供参考，不构成投资建议。
本文源自：市场资讯
作者：电报君
特别声明：以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布，本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.
